Management

Proniras has assembled a seasoned management team, board of directors, and key product development experts that understand well the challenges associated with the development of new treatments for substance use and specialty central nervous system (CNS) disorders.

Thong Q. Le

President & CEO

Lindsay Rayle

Vice President of Finance

Christopher Toombs, PhD, DABT

Cofounder & Chief Scientific Officer

OPERATING TEAM

Andrew Chambers, MD

Addiction Psychiatry
PI for first clinical trial

Greg Coulter, Ph.D.

Drug Substance/Drug Product

Gregory Dietsch, PhD, DABT

Toxicology and Pharmacokinetics

Ken Ferguson, Ph.D.

Development

Michelle Rose, Ph.D.

Regulatory

Keri Urwin, MBA

Clinical Operations

Michelle Woods

Quality

Board of Directors

Thong Q. Le

Steven Gillis, PhD

Atul Saran